nodes	percent_of_prediction	percent_of_DWPC	metapath
Vapreotide—Octreotide—MPO—atherosclerosis	0.00748	0.748	CrCbGaD
Vapreotide—Desmopressin—PTGS2—atherosclerosis	0.00252	0.252	CrCbGaD
Vapreotide—SSTR2—GPCR ligand binding—CCL2—atherosclerosis	0.000993	0.001	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CCL4—atherosclerosis	0.000989	0.000999	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—TNF—atherosclerosis	0.000986	0.000996	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—KNG1—atherosclerosis	0.000974	0.000984	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—AGTR1—atherosclerosis	0.000968	0.000978	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—KNG1—atherosclerosis	0.000959	0.000968	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—UTS2—atherosclerosis	0.000955	0.000965	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—AGTR1—atherosclerosis	0.000953	0.000963	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—AGT—atherosclerosis	0.000949	0.000959	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—APOA2—atherosclerosis	0.000924	0.000933	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CX3CR1—atherosclerosis	0.000916	0.000925	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CASR—atherosclerosis	0.000916	0.000925	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CCL3—atherosclerosis	0.0009	0.000909	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CX3CL1—atherosclerosis	0.000898	0.000907	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—EDNRA—atherosclerosis	0.000897	0.000906	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—CCR2—atherosclerosis	0.000897	0.000906	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—EDN1—atherosclerosis	0.00089	0.000899	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—KNG1—atherosclerosis	0.000885	0.000894	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—CCL5—atherosclerosis	0.000883	0.000892	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—UTS2—atherosclerosis	0.000881	0.00089	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—AGTR1—atherosclerosis	0.000879	0.000888	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—F2—atherosclerosis	0.000877	0.000886	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—GHRL—atherosclerosis	0.000874	0.000883	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CNR2—atherosclerosis	0.000851	0.00086	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—CXCL8—atherosclerosis	0.000851	0.000859	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—MMP3—atherosclerosis	0.000849	0.000858	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CX3CR1—atherosclerosis	0.000845	0.000854	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—APOA4—atherosclerosis	0.000845	0.000854	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CASR—atherosclerosis	0.000845	0.000854	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—atherosclerosis	0.000842	0.000851	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—PRKCG—atherosclerosis	0.000839	0.000848	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CX3CL1—atherosclerosis	0.000829	0.000837	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—EDN1—atherosclerosis	0.000821	0.000829	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—CCL5—atherosclerosis	0.000815	0.000823	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—EDNRA—atherosclerosis	0.000814	0.000822	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CCR2—atherosclerosis	0.000814	0.000822	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	0.000812	0.00082	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—EDN1—atherosclerosis	0.000808	0.000816	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—CCL5—atherosclerosis	0.000802	0.00081	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—IL6—atherosclerosis	0.000796	0.000804	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—GHRL—atherosclerosis	0.000794	0.000802	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CNR2—atherosclerosis	0.000786	0.000794	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—CXCL8—atherosclerosis	0.000785	0.000793	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—MMP3—atherosclerosis	0.000784	0.000792	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—CCL2—atherosclerosis	0.000782	0.00079	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CCL4—atherosclerosis	0.000779	0.000786	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—PRKCG—atherosclerosis	0.000775	0.000782	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—KNG1—atherosclerosis	0.000767	0.000775	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—AGTR1—atherosclerosis	0.000762	0.00077	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—PRKCG—atherosclerosis	0.000762	0.00077	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—VWF—atherosclerosis	0.000759	0.000766	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—APOC3—atherosclerosis	0.000754	0.000762	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—LDLR—atherosclerosis	0.000749	0.000757	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—EDN1—atherosclerosis	0.000746	0.000753	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CCL5—atherosclerosis	0.00074	0.000747	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—AGT—atherosclerosis	0.000738	0.000746	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CCL3—atherosclerosis	0.000732	0.000739	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—APOA2—atherosclerosis	0.000727	0.000735	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—PRKCG—atherosclerosis	0.000703	0.00071	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—NCF1—atherosclerosis	0.000701	0.000708	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—VWF—atherosclerosis	0.0007	0.000707	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—KNG1—atherosclerosis	0.000697	0.000704	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—APOC3—atherosclerosis	0.000696	0.000703	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—UTS2—atherosclerosis	0.000694	0.000701	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—AGTR1—atherosclerosis	0.000692	0.000699	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—LDLR—atherosclerosis	0.000692	0.000699	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—F2—atherosclerosis	0.000682	0.000689	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—AGT—atherosclerosis	0.000681	0.000688	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CCL3—atherosclerosis	0.000676	0.000682	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—AGT—atherosclerosis	0.000671	0.000677	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CX3CR1—atherosclerosis	0.000665	0.000672	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CASR—atherosclerosis	0.000665	0.000672	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—EDNRA—atherosclerosis	0.000662	0.000669	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CCR2—atherosclerosis	0.000662	0.000669	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CYBA—atherosclerosis	0.000659	0.000666	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000653	0.00066	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CX3CL1—atherosclerosis	0.000652	0.000659	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—NCF1—atherosclerosis	0.000647	0.000653	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—EDN1—atherosclerosis	0.000646	0.000653	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—GHRL—atherosclerosis	0.000645	0.000652	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PLAT—atherosclerosis	0.000645	0.000652	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PARP1—atherosclerosis	0.000645	0.000652	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—CCL5—atherosclerosis	0.000641	0.000648	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—F2—atherosclerosis	0.00063	0.000636	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—F2—atherosclerosis	0.00062	0.000626	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—AGT—atherosclerosis	0.000619	0.000625	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CNR2—atherosclerosis	0.000619	0.000625	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—CXCL8—atherosclerosis	0.000618	0.000624	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—MMP3—atherosclerosis	0.000617	0.000623	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atherosclerosis	0.000616	0.000622	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CCR2—atherosclerosis	0.000611	0.000617	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—EDNRA—atherosclerosis	0.000611	0.000617	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—PRKCG—atherosclerosis	0.00061	0.000616	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CYBA—atherosclerosis	0.000608	0.000614	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000603	0.000609	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PARP1—atherosclerosis	0.000595	0.000601	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—GHRL—atherosclerosis	0.000595	0.000601	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PLAT—atherosclerosis	0.000595	0.000601	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—PIK3CG—atherosclerosis	0.000593	0.000599	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—EDN1—atherosclerosis	0.000587	0.000593	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CCL5—atherosclerosis	0.000582	0.000588	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—F2—atherosclerosis	0.000572	0.000578	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—KNG1—atherosclerosis	0.000566	0.000572	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—AGTR1—atherosclerosis	0.000563	0.000569	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—PRKCG—atherosclerosis	0.000554	0.000559	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—CCL2—atherosclerosis	0.000552	0.000558	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—VWF—atherosclerosis	0.000551	0.000557	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PLG—atherosclerosis	0.000549	0.000554	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—APOC3—atherosclerosis	0.000548	0.000553	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—PIK3CG—atherosclerosis	0.000547	0.000553	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—LDLR—atherosclerosis	0.000545	0.00055	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—AGT—atherosclerosis	0.000537	0.000542	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CCL3—atherosclerosis	0.000532	0.000537	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—KNG1—atherosclerosis	0.000523	0.000528	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—SOCS3—atherosclerosis	0.000519	0.000525	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—AGTR1—atherosclerosis	0.000519	0.000525	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CCL2—atherosclerosis	0.00051	0.000515	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—NCF1—atherosclerosis	0.000509	0.000515	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PLG—atherosclerosis	0.000506	0.000511	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—MMP3—atherosclerosis	0.000502	0.000507	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—IGF2—atherosclerosis	0.0005	0.000505	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—F2—atherosclerosis	0.000496	0.000501	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—AGT—atherosclerosis	0.000487	0.000492	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—APOB—atherosclerosis	0.000485	0.00049	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CCR2—atherosclerosis	0.000481	0.000486	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—EDNRA—atherosclerosis	0.000481	0.000486	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—CXCL8—atherosclerosis	0.000481	0.000486	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—SOCS3—atherosclerosis	0.000479	0.000484	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CYBA—atherosclerosis	0.000479	0.000484	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—EDN1—atherosclerosis	0.000477	0.000482	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000474	0.000479	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CCL5—atherosclerosis	0.000474	0.000478	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PLAT—atherosclerosis	0.000469	0.000473	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—GHRL—atherosclerosis	0.000469	0.000473	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PARP1—atherosclerosis	0.000469	0.000473	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—LPL—atherosclerosis	0.000463	0.000468	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—MMP3—atherosclerosis	0.000463	0.000468	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—IGF2—atherosclerosis	0.000461	0.000466	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PRKCG—atherosclerosis	0.00045	0.000455	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—F2—atherosclerosis	0.00045	0.000455	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—APOB—atherosclerosis	0.000448	0.000452	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—CXCL8—atherosclerosis	0.000444	0.000448	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—EDN1—atherosclerosis	0.00044	0.000445	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—SPP1—atherosclerosis	0.000439	0.000443	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CCL5—atherosclerosis	0.000437	0.000441	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—CXCL8—atherosclerosis	0.000437	0.000441	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—PIK3CG—atherosclerosis	0.000431	0.000435	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—LPL—atherosclerosis	0.000427	0.000432	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PRKCG—atherosclerosis	0.000415	0.00042	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—KNG1—atherosclerosis	0.000411	0.000416	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—AGTR1—atherosclerosis	0.000409	0.000413	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PDGFB—atherosclerosis	0.000406	0.00041	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—SPP1—atherosclerosis	0.000405	0.000409	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CXCL8—atherosclerosis	0.000403	0.000407	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CCL2—atherosclerosis	0.000401	0.000405	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PLG—atherosclerosis	0.000399	0.000403	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—AGT—atherosclerosis	0.000396	0.0004	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—APOE—atherosclerosis	0.000388	0.000392	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—LEP—atherosclerosis	0.000388	0.000392	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CAV1—atherosclerosis	0.000385	0.000388	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—APOA1—atherosclerosis	0.000384	0.000388	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—SOCS3—atherosclerosis	0.000377	0.000381	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PDGFB—atherosclerosis	0.000374	0.000378	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—ESR1—atherosclerosis	0.000371	0.000374	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—F2—atherosclerosis	0.000366	0.00037	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—AGT—atherosclerosis	0.000366	0.000369	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—MMP3—atherosclerosis	0.000365	0.000368	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—IGF2—atherosclerosis	0.000363	0.000367	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—LEP—atherosclerosis	0.000358	0.000362	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—APOE—atherosclerosis	0.000358	0.000362	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CAV1—atherosclerosis	0.000355	0.000358	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—APOA1—atherosclerosis	0.000354	0.000358	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—APOB—atherosclerosis	0.000352	0.000356	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PIK3CG—atherosclerosis	0.00035	0.000354	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—CXCL8—atherosclerosis	0.000349	0.000353	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—EDN1—atherosclerosis	0.000347	0.00035	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CCL5—atherosclerosis	0.000344	0.000348	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—ESR1—atherosclerosis	0.000342	0.000345	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—F2—atherosclerosis	0.000338	0.000341	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—LPL—atherosclerosis	0.000336	0.00034	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—MAPK3—atherosclerosis	0.000335	0.000339	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—INS—atherosclerosis	0.000332	0.000335	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PRKCG—atherosclerosis	0.000327	0.00033	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CCL2—atherosclerosis	0.000326	0.00033	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PIK3CG—atherosclerosis	0.000323	0.000327	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—IGF1—atherosclerosis	0.000321	0.000324	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—SPP1—atherosclerosis	0.000319	0.000322	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CXCL8—atherosclerosis	0.000317	0.00032	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—MAPK3—atherosclerosis	0.00031	0.000313	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—INS—atherosclerosis	0.000306	0.000309	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—SERPINE1—atherosclerosis	0.000305	0.000308	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CCL2—atherosclerosis	0.000301	0.000304	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—IGF1—atherosclerosis	0.000296	0.000299	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PDGFB—atherosclerosis	0.000295	0.000298	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—NOS3—atherosclerosis	0.000291	0.000294	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—AGT—atherosclerosis	0.000288	0.000291	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—LEP—atherosclerosis	0.000282	0.000285	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—APOE—atherosclerosis	0.000282	0.000285	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—SERPINE1—atherosclerosis	0.000281	0.000284	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CAV1—atherosclerosis	0.000279	0.000282	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—APOA1—atherosclerosis	0.000279	0.000282	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—ESR1—atherosclerosis	0.000269	0.000272	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—NOS3—atherosclerosis	0.000268	0.000271	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—F2—atherosclerosis	0.000266	0.000269	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CXCL8—atherosclerosis	0.000258	0.000261	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PIK3CG—atherosclerosis	0.000255	0.000257	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—AKT1—atherosclerosis	0.000249	0.000252	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—IL6—atherosclerosis	0.000245	0.000248	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—MAPK3—atherosclerosis	0.000244	0.000246	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—INS—atherosclerosis	0.000241	0.000243	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CXCL8—atherosclerosis	0.000238	0.00024	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CCL2—atherosclerosis	0.000237	0.000239	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—MMP9—atherosclerosis	0.000233	0.000236	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—IGF1—atherosclerosis	0.000233	0.000235	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—NFKB1—atherosclerosis	0.000231	0.000233	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—AKT1—atherosclerosis	0.00023	0.000232	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—MAPK8—atherosclerosis	0.000227	0.000229	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—IL6—atherosclerosis	0.000226	0.000229	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—AKT1—atherosclerosis	0.000226	0.000229	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—SERPINE1—atherosclerosis	0.000221	0.000224	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—MMP9—atherosclerosis	0.000215	0.000217	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—NFKB1—atherosclerosis	0.000213	0.000215	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—NOS3—atherosclerosis	0.000211	0.000213	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—VEGFA—atherosclerosis	0.000209	0.000212	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—MAPK8—atherosclerosis	0.000209	0.000211	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—AKT1—atherosclerosis	0.000209	0.000211	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—STAT3—atherosclerosis	0.000207	0.00021	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—MAPK3—atherosclerosis	0.000198	0.0002	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—VEGFA—atherosclerosis	0.000193	0.000195	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—TGFB1—atherosclerosis	0.000192	0.000194	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—STAT3—atherosclerosis	0.000191	0.000193	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CXCL8—atherosclerosis	0.000187	0.000189	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—MAPK3—atherosclerosis	0.000183	0.000185	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—AKT1—atherosclerosis	0.000181	0.000183	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—IL6—atherosclerosis	0.000178	0.00018	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—TGFB1—atherosclerosis	0.000177	0.000179	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—MMP9—atherosclerosis	0.00017	0.000171	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—NFKB1—atherosclerosis	0.000168	0.000169	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—MAPK8—atherosclerosis	0.000165	0.000167	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—AKT1—atherosclerosis	0.000164	0.000166	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—VEGFA—atherosclerosis	0.000152	0.000154	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—STAT3—atherosclerosis	0.000151	0.000152	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—IL6—atherosclerosis	0.000145	0.000146	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—MAPK3—atherosclerosis	0.000144	0.000145	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—TGFB1—atherosclerosis	0.00014	0.000141	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—IL6—atherosclerosis	0.000134	0.000135	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—AKT1—atherosclerosis	0.000134	0.000135	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—AKT1—atherosclerosis	0.000123	0.000125	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—IL6—atherosclerosis	0.000105	0.000106	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—AKT1—atherosclerosis	9.71e-05	9.81e-05	CbGpPWpGaD
